Efficacy of folic acid in children with migraine, hyperhomocysteinemia and MTHFR polymorphisms

Headache

Volumn 47, Issue 9, 2007, Pages 1342-1344

  Di Rosa, Gabriella ^a   Attinà, Sarina ^a   Spanò, Maria ^a   Ingegneri, Giulia ^a   Sgrò, Domenica L ^a   Pustorino, Giuseppina ^a   Bonsignore, Maria ^a   Trapani Lombardo, Vincenzo ^b   Tortorella, Gaetano ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

Children; Folic acid; Homocysteine; Migraine; MTHFR

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG EFFICACY; FEMALE; FOLATE METABOLISM; GENE; GENETIC VARIABILITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MIGRAINE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; FEMALE; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; POLYMORPHISM, GENETIC; TREATMENT OUTCOME;

EID: 35248814759     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00932.x     Document Type: Article

References (15)

1. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003 111 : 84 90.
2. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000 96 : 762 764.
3. Van der Put NM, Gabreels F, Stevens EM, et al A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet. 1998 62 : 1044 1051.
4. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene variant C667T influences susceptibility to migraine with aura. BMC Med. 2004 2 : 3.
5. Prengler M, Sturt N, Krywawych S, Surtees R, Liesner R, Kirkham F. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: A potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol. 2001 43 : 220 225.
6. Grandone E, Corrao AM, Colaizzo D, et al Homocysteine metabolism in families from Southern Italy with neural tube defects: Role of genetic and nutritional determinants. Prenat Diagn. 2006 26 : 1 5.
7. Oterino A, Valle N, Bravo Y, et al MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia. 2004 24 : 491 494.
8. Scher AI, Terwindt GM, Verschuren WM, et al Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol. 2006 59 : 372 375.
9. Bottini F, Celle ME, Calevo MG, et al Metabolic and genetic risk factors for migraine in children. Cephalalgia. 2006 26 : 731 737.
10. Gallai V, Sarchielli P, Carboni F, Benedetti P, Mastropaolo C, Puca F. Applicability of the 1988 IHS criteria to headache patients under the age of 18 years attending 21 Italian headache clinics. Juvenile Headache Collaborative Study Group. Headache. 1995 35 : 146 153.
11. de Bree A, Verschuren WM, Bjorke-Monsen AL, et al Effect of the methylenetetrahydrofolate reductase 677C-
12. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C
13. Goadsby PJ. Current concepts of the pathophysiology of migraine. Neurol Clin. 1997 15 : 27 42.
14. Ferrari MD. Migraine. Lancet. 1998 351 : 1043 1051.
15. Stamler JS, Osborne JA, Jaraki O, et al Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993 91 : 308 318.